EN
HI
Summary
As of 28 Oct, 2026, Biocon stock price is ₹346.85. During the trading session, the stock has moved between an intraday low of ₹330.60 and an intraday high of ₹348.20. Over the last 52 weeks, Biocon has traded between ₹318.40 and ₹447.15.
The stock has recorded a trading volume of 26,04,518 shares,. Its Average Traded Price (ATP) is ₹341.35, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 51 @ ₹346.85.
Biocon has an upper circuit limit of ₹365.65 and a lower circuit limit of ₹299.25. The total value traded stands at ₹88.91 CR, and the delivery percentage for the day is 49.32%.
The stock is currently traded with a market lot size of 1. Biocon also offers a dividend yield of 0.15%.
Biocon Share Price Chart
Biocon Share Key Metrics
Volume
26.05 L
Market Cap
54179.18 CR
LTQ@LTP
51@346.85
ATP
341.35
Var Margin
14.4 %
Circuit Range
299.25-365.65
Delivery %
49.32 %
Value
88.91 CR
ASM/GSM
No
Market Lot
1
Biocon Fundamentals
P/E Ratio
109.83
P/B Ratio
1.6
Div. Yield
0.15
Sector P/E
39.19
Sector P/B
3.23
Sec. Div. Yield
0.53
Biocon Resistance and Support
Pivot 331.7
Resistance
First Resistance
335.4
Second Resistance
338.35
Third Resistance
342.05
Support
First Support
328.75
Second Support
325.05
Third Support
322.1
Biocon Futures & Options
Biocon Option Chain
View Price, OI, Greeks & More...
23NOV26
348.10
13.00 (3.88%)
29DEC26
350.00
12.70 (3.77%)
25JAN27
351.85
0.00 (0.00%)
BIOCON|23NOV26 CE 345.00
12.75
5.65 (79.58%)
BIOCON|23NOV26 PE 350.00
12.05
-7.95 (-39.75%)
Biocon Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Oct 28 2026 | 331.45 | 346.85 | 4.33% | 348.2 | 330.6 |
| Tue Oct 27 2026 | 329.79 | 332.45 | 1.11% | 334.64 | 328 |
| Mon Oct 26 2026 | 323 | 328.79 | 1.64% | 329.79 | 321.29 |
Biocon Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Quarterly Results |
| 2026-08-05 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-10-01 | Redemption (Part) of NCD |
| 2025-08-07 | Quarterly Results |
| 2025-05-08 | Audited Results & Final Dividend |
| 2025-04-23 | Others |
| 2025-04-04 | To consider Fund Raising |
| 2025-01-30 | Quarterly Results & Others |
| 2025-01-27 | Others |
| 2024-10-30 | Quarterly Results |
Biocon News
Biocon Ltd - 532523 - Board Meeting Intimation for To Approve And Take On Record The Un-Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended On September 30, 2026
Biocon's board will meet on 4 November 2026 for the financial results of Q2 FY27. An earnings conference call for analysts and investors will follow on the same day.
Oct 26 2026 20:31:26
Biocon Ltd - 532523 - Company Statement
Biocon signed a license agreement with Janssen Sciences Ireland to commercialize Yesintek (biosimilar to Stelara) in nine global markets including Australia, Brazil, and China. This grants immediate market entry rights for the autoimmune treatment.
Oct 26 2026 08:27:48
Biocon Management
| Name | Position |
|---|---|
| Kiran Mazumdar-Shaw | Chairperson |
| Ravi Rasendra Mazumdar | Non Independent & Non Executive Director |
Biocon Similar Stocks
Alkem Laboratories Ltd.
5058.50
-19.50 (0.38%)
Aster DM Quality Care Ltd.
668.45
5.65 (0.85%)
Fortis Healthcare Ltd.
754.55
18.05 (2.45%)
Abbott India Ltd.
26070.00
555.00 (2.18%)
Ipca Laboratories Ltd.
1932.60
-48.20 (2.43%)
Gland Pharma Ltd.
3045.40
85.10 (2.87%)
Anthem Biosciences Ltd.
833.85
-3.30 (0.39%)
Ajanta Pharma Ltd.
3418.40
64.80 (1.93%)
Glaxosmithkline Pharmaceuticals Ltd.
2511.10
38.70 (1.57%)
Biocon FAQs
The Buying Price of Biocon share is 346.85 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Biocon stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Biocon, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Biocon shares is 109.83. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Biocon shares is 1.6. Useful to assess the stock's value relative to its book value.
To assess Biocon’s valuation compare Sector P/E, P/B which are 39.19 & 3.23 with sector averages, along with growth rates and financial metrics.
The Market Cap of Biocon is 54179.18 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Biocon share price is 447.15 & 318.40. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Biocon belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in BIOCON
